HBIO
Harvard Bioscience Inc
Price:  
4.41 
USD
Volume:  
25,639.00
United States | Life Sciences Tools & Services
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

HBIO Relative Valuation

-149.8%
Upside

As of 2024-02-26, the Relative Valuation of Harvard Bioscience Inc (HBIO) is (2.20) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.41 USD, the upside of Harvard Bioscience Inc based on Relative Valuation is -149.8%.

The range of the Relative Valuation is (2.27) - (2.13) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 29.7x - 32.0x 30.8x
Forward P/E multiples 25.6x - 27.8x 26.5x
Fair Price (2.27) - (2.13) (2.20)
Upside -151.5% - -148.2% -149.8%
4.41 USD
Stock Price
(2.20) USD
Fair Price

HBIO Relative Valuation - Historical P/E Data

Date P/E
2024-02-23 -57.57
2024-02-22 -57.44
2024-02-21 -57.96
2024-02-20 -56.53
2024-02-16 -59.01
2024-02-15 -63.45
2024-02-14 -61.23
2024-02-13 -56.92
2024-02-12 -62.79
2024-02-09 -61.75
2024-02-08 -60.97
2024-02-07 -60.71
2024-02-06 -61.10
2024-02-05 -58.75
2024-02-02 -59.01
2024-02-01 -59.01
2024-01-31 -57.44
2024-01-30 -59.66
2024-01-29 -60.58
2024-01-26 -59.53
2024-01-25 -60.18
2024-01-24 -58.62
2024-01-23 -60.18
2024-01-22 -58.88
2024-01-19 -56.14
2024-01-18 -56.14
2024-01-17 -57.31
2024-01-16 -59.79
2024-01-12 -63.97
2024-01-11 -60.84
2024-01-10 -62.14
2024-01-09 -63.58
2024-01-08 -65.01
2024-01-05 -63.45
2024-01-04 -64.88
2024-01-03 -64.88
2024-01-02 -70.37
2023-12-29 -69.84
2023-12-28 -70.63
2023-12-27 -71.67
2023-12-26 -70.37
2023-12-22 -70.50
2023-12-21 -68.93
2023-12-20 -65.28
2023-12-19 -64.36
2023-12-18 -63.97
2023-12-15 -63.97
2023-12-14 -64.23
2023-12-13 -65.28
2023-12-12 -64.49